Natco Pharma Ltd. - Research Center
524816 NATCOPHARM Group (A) BSE data
Add to watchlist
| Results | |
| Statement |
Cash flow
|
| More |
Cash flow
(Rs crore)
| Mar ' 23 | Mar ' 22 | Mar ' 21 | Mar ' 20 | Mar ' 19 | |
|---|---|---|---|---|---|
| Profit before tax | 770.70 | 155.90 | 392.20 | 583.10 | 847.40 |
| Net cashflow-operating activity | 784.40 | 57.70 | 183.50 | 422.50 | 698.80 |
| Net cash used in investing activity | -436.60 | -92.50 | -3.20 | -165.00 | -645.20 |
| Netcash used in fin. activity | -346.80 | 35.60 | -183.10 | -261.10 | -52.20 |
| Net inc/dec in cash and equivlnt | 1.00 | 0.80 | -2.80 | -3.60 | 1.40 |
| Cash and equivalnt begin of year | 5.90 | 5.10 | 7.90 | 11.50 | 10.10 |
| Cash and equivalnt end of year | 6.90 | 5.90 | 5.10 | 7.90 | 11.50 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis